Nucl Med Mol Imaging.  2009 Aug;43(4):352-356.

Diffuse Bone Marrow Uptake of 99mTc-MIBI in A Case of Intravascular Large B-cell Lymphoma

Affiliations
  • 1Department of Nuclear Medicine, Seoul National University College of Medicine, Seoul, Korea. paengjc@snu.ac.kr
  • 2Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.

Abstract

Intravascular large B-cell lymphoma (IVLBCL) is a subtype of diffuse large cell lymphoma, characterized by proliferation of lymphoid cells in the intravascular space of various organs without causing a mass effect. Although 18F-FDG PET is a powerful imaging tool in lymphoma, the usefulness of 18F-FDG PET in the assessment of IVLBCL is still controversial. 99mTc-MIBI, a tumor imaging radiopharmaceutical with a different mechanism from that of 18F-FDG, has been reported to be also effective in lymphoma. However, there is nearly no report on the efficacy of 99mTc-MIBI in the assessment of IVLBCL. We present one case of IVLBCL that showed 99mTc-MIBI accumulation in the involved bone marrow as an incidental finding, which was discrepant from that of 18F-FDG PET.

Keyword

Intravascular large B-cell lymphoma; 99mTc-MIBI; 18F-FDG PET

MeSH Terms

B-Lymphocytes
Bone Marrow
Fluorodeoxyglucose F18
Incidental Findings
Lymphocytes
Lymphoma
Lymphoma, B-Cell
Lymphoma, Large B-Cell, Diffuse
Fluorodeoxyglucose F18
Full Text Links
  • NMMI
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr